Clinical Trials Browser

Phase 1/2 × Non-Malignant Neoplasm × Clear all

NCT04083183 2025-12-18

Total Body Irradiation and Astatine-211-Labeled BC8-B10 Monoclonal Antibody for the Treatment of Nonmalignant Diseases

Phase 1/2 Recruiting

Non-Malignant Neoplasm